Company Quick10K Filing
CBA Florida
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-25
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-21
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-11
10-Q 2011-03-31 Filed 2011-05-23
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-22
10-Q 2010-06-30 Filed 2010-08-18
10-Q 2010-03-31 Filed 2010-05-20
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-09-18
8-K 2020-06-26
8-K 2020-06-16
8-K 2020-06-02
8-K 2020-02-11
8-K 2018-08-14
8-K 2018-05-31
8-K 2018-05-29
8-K 2018-05-22
8-K 2018-05-16
8-K 2018-05-14
8-K 2018-05-14
8-K 2018-04-25
8-K 2018-04-02
8-K 2018-02-06

CBA Florida Financials

CBAI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2062361963013333693943946135957098027026997516447777891,0441,1641,1209268217339601,0701,19613,24012,04412,41311,89311,50011,368
Accounts Receivable44638821323526223718222024620915621526932328838553335021413612211349224262672232711292236
Inventory10658
PP&E6376697357588127051,3388768097471,306642613139768126107815107948280660544928528528528528528500
Assets7,5647,5897,3507,4157,4477,3166,3526,3756,4106,0785,7585,6473,9593,8633,7943,8743,7023,6233,5303,3163,1282,8362,6002,7132,8562,88416,95715,76815,57015,04414,66514,544
Accounts Payable1,1369541,2329501,04060853858448951559352359145836340721115311041815111697110371358235671108051
Long-Term Debt1,7101,6491,4781,1981,6671,7981,7491,5291,4361,4231,4411,4951,4961,4921,3491,16881870275579259635793000
Liabilities8,0067,0368,2297,3146,7656,0065,8355,7695,9106,2696,4486,4407,2474,6684,5554,6943,4213,2273,1563,0952,7422,5522,1381,7521,6871,8721,8632,1481,0531,412929592598
Stockholders' Equity-93292-95651621474-146-19-33-243-520-724-1,559-708-691474
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,4301,4931,2871,5561,8671,5141,3541,4521,4881,4871,5481,4161,5361,1971,1951,2781,4311,134986793775734746746748-2,240000000
Cost of Revenue-460-4373,2244351,390422527440492475-3,393439473423392402546408340201173190171176162-509000000
Gross Profit9711,0567991,1211,3511,0928271,0121,0141,0129339761,063774803876885726646592602544575570585-1,731000000
R&D
SG&A-1,877-1,55013,1671,3864,3191,1251,9931,1071,1711,2661,5731,3221,364754721774659701665601498726502445415341429777297103149198
Tax0000000000-620000000000000000-13-9-28
Net Income-1,010-979-2,142-1,26014811009180-1,292-545-8801,69517-20922821-8-321402122150177-423713,788-94-42-42-126
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-106-87-194146-179417129217-13163222-95829-17720821818610422265195-118201-2,167-434-1,038-1,612-519-393-132
Cash Investing-116-171-160-91235-387-1293-5-11-118-1016-8-15-669159410302500
Cash Financing251218459-23-2-60000-300-20000-275-300-300000000